Clinical Trial Update: Tesetaxel as First-line Therapy for Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update exploring tesetaxel as first-line therapy for metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• tesetaxel (tesetaxel)

Snippet

Sponsor: Genta Incorporated | Conditions: Breast Neoplasm | Phase 2 | Status: UNKNOWN